Types of brain cancer tumors
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Types of Brain Cancer Tumors
Brain cancer encompasses a variety of tumor types, each with distinct characteristics, incidence rates, and treatment challenges. Understanding these differences is crucial for diagnosis and management.
Glioblastoma: The Most Common Malignant Brain Tumor
Glioblastoma is the most prevalent and aggressive malignant primary brain tumor, accounting for approximately 14.2% to 14.6% of all brain tumors and 50.1% of all malignant brain tumors . It is more common in males and has a poor prognosis, with a five-year relative survival rate of only 4% to 7%. Glioblastomas are characterized by rapid growth and a tendency to infiltrate surrounding brain tissue, making them difficult to treat effectively .
Meningioma: The Most Common Non-Malignant Brain Tumor
Meningiomas are the most common non-malignant brain tumors, representing 37.6% to 39.7% of all brain tumors . These tumors originate from the meninges, the protective layers surrounding the brain and spinal cord. Meningiomas are more frequently diagnosed in females and are often benign, though they can become problematic due to their location and potential to cause neurological symptoms.
Pediatric Brain Tumors: Unique Challenges
In children and adolescents, brain tumors present unique challenges. The incidence rate of primary brain and other CNS tumors in this age group is approximately 6.06 to 6.20 per 100,000 population . Pediatric brain tumors often require specialized treatment approaches and have different prognostic factors compared to adult brain tumors.
Brain Metastases: Secondary Brain Tumors
Brain metastases are secondary brain tumors that originate from cancers elsewhere in the body, such as lung, breast, melanoma, and colorectal cancers. These metastases are more common than primary brain tumors and can occur in 10% to 45% of patients with systemic cancer. The treatment of brain metastases involves a multidisciplinary approach, including neurosurgery, radiation oncology, and medical oncology.
Advances in Molecular Classification
Recent advances in molecular biology have led to a better understanding of the genetic alterations in brain tumors. For instance, the revised 2016 WHO classification of CNS tumors incorporates molecular features such as IDH mutations and 1p/19q codeletions, which are crucial for diagnosis, grading, and treatment planning. This molecular classification helps in providing a more accurate prognosis and tailoring personalized treatment strategies.
Conclusion
Brain cancer encompasses a diverse group of tumors, each with unique characteristics and treatment challenges. Glioblastomas and meningiomas are the most common malignant and non-malignant brain tumors, respectively. Pediatric brain tumors and brain metastases present additional complexities. Advances in molecular classification are paving the way for more precise and effective treatments. Understanding these tumor types is essential for improving patient outcomes and advancing research in neuro-oncology.
Sources and full results
Most relevant research papers on this topic